New hope for stroke patients: drug trial aims to boost brain recovery after clot removal
NCT ID NCT07449910
Summary
This study is testing if adding the drug baricitinib to the standard emergency procedure to remove a large blood clot in the brain helps people recover better from a major stroke. It will involve 750 adults who have had this type of stroke and received the clot-removal treatment. The main goal is to see if the drug reduces long-term disability by calming harmful brain inflammation after the procedure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTERIOR CEREBRAL ARTERY STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of University of Science and Technology of China, Hefei, Recruiting
Hefei, Anhui, 230001, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.